LEO Pharma - M&A Summary and Business Overview

Life ScienceCompany

LEO Pharma M&A Summary

LEO Pharma has acquired 1 company. It has also divested 1 asset.

LEO Pharma’s largest acquisition to date was in 2015, when it acquired Astellas Pharma - Global Dermatology for $761M. It’s largest disclosed sale occurred in 2020, when it sold LEO PDE4 Inhibitor to UNION therapeutics A/S for $200M. LEO Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

LEO Pharma Business Overview

Where is LEO Pharma headquartered?

LEO Pharma is headquartered in Ballerup, Denmark.

How many employees does LEO Pharma have?

LEO Pharma has 4,285 employees.

What sector is LEO Pharma in?

LEO Pharma is a life science company.

When was LEO Pharma founded?

LEO Pharma was founded in 1908.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2
  • M&A Advisors 2

LEO Pharma

LEO Pharma A/S

Industriparken 55,
Ballerup, 2750
Denmark,
+45 4494 5888
www.leo-pharma.com

LEO Pharma engages in medical dermatology with a robust R&D pipeline, a wide range of therapies, and a pioneering spirit. LEO Pharma supports people in managing their skin conditions. LEO Pharma was founded in 1908 and is based in Ballerup, Denmark.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $761M $761M
Sell (0.2/yr) # - 1 - - - - 1
vol $200M $200M
  2

Most Recent M&A

Company Date Value Type
LEO PDE4 Inhibitor 2020-07-21 200M USD Divestiture
Ballerup, Denmark
Astellas Pharma - Global Dermatology 2015-11-11 761M EUR Divestiture
, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 761M (100%) 1 (100%) 200M (100%)
Total 1 $761M 1 $200M

By Geo

State/Country Buy Value Sell Value
Denmark - - 1 200M
United States 1 761M - -
Domestic - - 1 (100%) 200M (100%)
Cross-border 1 (100%) 761M (100%) - -
Total 1 $761M 1 $200M

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
1
Legal Deals
Kromann Reumert
1

Deal Values

buy # Total
$100M to $1B 1 $761M
TOTAL $761M
Largest Astellas Pharma - Global Dermatology
$761M (2015-11-11)
sell # Total
$100M to $1B 1 $200M
TOTAL $200M
Largest LEO PDE4 Inhibitor
$200M (2020-07-21)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for LEO Pharma

Life Science Companies , Denmark Companies